Identifying novel strategies to promote tissue regeneration

确定促进组织再生的新策略

• 批准号: 8118452
• 负责人: Iswar K. Hariharan
• 金额: $ 29.26万
• 依托单位: UNIVERSITY OF CALIFORNIA BERKELEY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8118452
• 关键词: Adult; Animal Model; Animals; Apoptosis; Caenorhabditis elegans; Cell Cycle Progression; Cell Cycle Regulation; Clinical Management; Complex; Degenerative Disorder; Development; Disease; Drosophila genus; Embryonic Development; Genes; Genetic; Genetic Screening; Growth; Histocompatibility Testing; In Situ; Injury; Medical; Mutation; Myocardial Infarction; Natural regeneration; Newts; Operative Surgical Procedures; Organ; Patients; Public Health; Staging; Stroke; System; Time; Tissues; Wound Healing; Yeasts; Zebrafish; cell killing; imaginal disc; improved; novel strategies; regenerative; tissue regeneration; tool

DESCRIPTION (provided by applicant): Many adult human organs are incapable of repairing tissue that has been damaged as a result of injury or disease. Following myocardial infarctions, strokes and a variety of degenerative diseases, there is no effective way of replacing the damaged or lost tissue by regenerative growth. Hence, improving the regenerative capacity of adult tissues would dramatically impact the clinical management of these medical conditions. Remarkably, these same tissues can regenerate in animals such as the zebrafish and the newt. Since the same type of tissue can regenerate in one animal but not another, important differences must exist between similar tissues in different species that allow regeneration in one case but not the other. The challenge is to be able to find ways to manipulate tissue that lacks or has lost the capacity to regenerate to become capable of regenerative growth once again. The basic mechanisms that regulate embryonic development, cell cycle regulation and apoptosis were elucidated using genetic studies in Drosophila, yeast and C. elegans. However, until now, it has been difficult to use these model organisms to study the mechanisms that regulate tissue regeneration. We have recently developed a system that allows the tools of Drosophila genetics to be used to identify genes that regulate the capacity for regenerative growth. By expressing a gene that can kill cells in a manner that is both spatially and temporally restricted, we can efficiently ablate portions of Drosophila imaginal discs and allow them to regenerate in situ without the need for complex surgical manipulations. Regeneration occurs efficiently at specific stages of larval development but cannot occur beyond a critical point during the third larval instar. We propose to look for changes in the expression of regulators of growth and cell-cycle progression that correlate with the loss of capacity for regenerative growth. We will conduct a large-scale genetic screen for mutations in specific genes that can enable regenerative growth at later stages of development (at a time when it normally does not occur). Using this approach we aim to find strategies that can be used to enhance a tissue's capacity for regenerative growth. to Public Health This project is aimed at finding ways to get damaged tissue to be replaced by normal and functional tissue (regeneration). This would be important in the treatment of patients who have had heart attacks, strokes or degenerative diseases.

描述（由申请人提供）：许多成人器官无法修复因受伤或疾病而受损的组织。心肌梗塞、中风和各种退行性疾病发生后，没有有效的方法通过再生生长来替代受损或丢失的组织。因此，提高成人组织的再生能力将极大地影响这些疾病的临床管理。值得注意的是，这些相同的组织可以在斑马鱼和蝾螈等动物体内再生。由于同一类型的组织可以在一种动物中再生，但在另一种动物中则不能，因此不同物种中的相似组织之间必然存在重要差异，这些差异在一种情况下允许再生，但在另一种情况下则不允许。面临的挑战是能够找到方法来操纵缺乏或已经失去再生能力的组织，使其再次能够再生生长。通过果蝇、酵母和线虫的遗传学研究阐明了调节胚胎发育、细胞周期调节和细胞凋亡的基本机制。然而，到目前为止，利用这些模式生物来研究调节组织再生的机制还很困难。我们最近开发了一个系统，可以使用果蝇遗传学工具来识别调节再生生长能力的基因。通过表达一种能够以空间和时间限制的方式杀死细胞的基因，我们可以有效地消融果蝇成虫盘的一部分，并让它们在原位再生，而不需要复杂的手术操作。再生在幼虫发育的特定阶段有效发生，但不能超过幼虫第三龄期间的临界点。我们建议寻找与再生生长能力丧失相关的生长和细胞周期进展调节因子表达的变化。我们将对特定基因的突变进行大规模的遗传筛查，这些突变可以在发育后期（通常不会发生）实现再生生长。使用这种方法，我们的目标是找到可用于增强组织再生生长能力的策略。公共卫生 该项目旨在寻找方法让受损组织被正常和功能组织取代（再生）。这对于治疗心脏病、中风或退行性疾病患者非常重要。